[Drug-induced diffuse infiltrative pneumopathies]

Abstract

Drug-induced diffuse infiltrative pneumopathies (DIP) represent an important chapter of respiratory diseases. More than 350 drugs have been described to be potentially pneumo-toxic and the list is constantly increasing. As for other forms of DIP, also for drug-induced lung injury a multidisciplinary approach within pulmonologist, radiologist and pathologist is essential for the better diagnostic accuracy. In this review, clinical-radiological-pathological-therapeutic aspects of the drugs which are more likely to induce DIP in the clinical practice are described.